Effects of Talampanel on Patients With Advanced Parkinson's Disease

Study Title
Effects of Talampanel on Patients With Advanced Parkinson's Disease
Teva Identifier
IXL-202-18-189
ClinicalTrials.gov Identifier
NCT00036296
Study Status
Completed
Trial Condition(s)
Dyskinesias | Parkinson Disease | Movement Disorders
Interventions
Drug: talampanel

Study Description

Please refer to ClinicalTrials.gov for a description of the trial



Key Participation Requirements

Gender
Female, Male
Age Range
40 Years to 85 Years
Trial Duration
12/01/2006 - 02/01/2007
Phase
Phase 1/2

Study Type

Interventional